Company Profile
name | SymBio Pharmaceuticals Limited | |
---|---|---|
English name | SymBio Pharmaceuticals Limited | |
location |
Toranomon Towers Office, 7th floor, 4-1-28 Toranomon, Minato-ku, Tokyo 105-0001, Japan MAP TEL: +81-3-5472-1125 FAX: +81-3-5472-3054 For Inquiry about brincidofovir: +81-3-6684-6663 |
|
Established | March 25, 2005 | |
capital | 17,952,692 thousands of yen (As of the end of December 2023) | |
Board of Directors | Fuminori Yoshida | Representative Director |
Shigetoshi Matsumoto | Board Director <Outside> | |
Bruce David Cheson | Board Director <Outside> | |
Eiji Ebinuma | Board Director <Outside> | |
Toshio Imabeppu | Board Director <Outside> | |
George Morstyn | Board Director <Outside> | |
Ralph Smalling | Board Director <Outside> | |
Kiyoshi Watanabe | Board Director, Full-Time Audit & Supervisory Committee Member<Outside> | |
Yasuhiro Tamo | Board Director, Audit & Supervisory Committee Member<Outside> | |
Koichi Shimomura | Board Director, Audit & Supervisory Committee Member<Outside> | |
Corporate Officers | Fuminori Yoshida | President and Chief Executive Officer |
Masaru Taguchi | Corporate Vice President and Chief Operation Officer | |
Takaaki Fukushima | Executive Corporate Officer and Chief Financial Officer | |
Paul Marston | Corporate Officer and General Counsel | |
Koji Fukushima | Corporate Officer and Deputy Chief Medical Officer | |
Masatoshi Hazama | Corporate Officer and Chief Scientific Officer | |
subsidiary | SymBio Pharma USA, Inc. Durham, North Carolina, USA |